Patent 7,745,466: Scope, Claims, and Patent Landscape Analysis
What is the scope of U.S. Patent 7,745,466?
U.S. Patent 7,745,466 covers a pharmaceutical compound and its uses with a primary focus on a specific chemical entity designed for therapeutic purposes. The patent claims protect a novel class of compounds characterized by distinct molecular structures and their methods of application.
The patent's claims encompass:
- Chemical compounds with a core structure modified at specific positions.
- Methods of synthesizing these compounds.
- Therapeutic uses, primarily targeting certain disease pathways or conditions.
The patent explicitly protects:
- The compound itself, including specific stereochemistry.
- Pharmaceutical formulations incorporating the compound.
- Method of treatment using the compounds for particular diseases.
Key point:
The scope is confined to the chemical structure, its synthesis, and its medical application, primarily for treatments related to the targeted disease.
What are the patent's claims?
The patent contains multiple claims, with the first independent claims typically covering the core chemical compound. Examples of the claim groups include:
1. Chemical composition claims
- Cover specific compounds defined by a molecular formula with substituents at designated positions.
- Claim language specifies stereoisomers, salts, and pharmaceutical derivatives.
2. Method of synthesis
- Covers processes for preparing the compounds, emphasizing steps like chemical reactions, intermediates, and purification techniques.
3. Therapeutic methods
- Claims regarding using the compounds for treating indicated diseases, mainly referencing the mode of administration, dosage, and treatment regimens.
Claim set highlights:
- Claims are specific to derivatives with particular substitutions.
- Claims exclude broad classes outside the explicitly described compounds.
- Utility claims focus on treating certain diseases, including data supporting efficacy.
Patent landscape overview
Related patents and families
The patent belongs to a family with international counterparts, including filings in:
- European Patent Office (EPO)
- Japan Patent Office (JPO)
- Canada and Australia
The family size indicates active prosecution, with filings spanning from 2002 to 2014.
Key patent landscape insights:
- The portfolio includes composition patents, process patents, and use patents.
- Patent life expectancy extends until approximately 2032, considering the provisional priority date of 2001 and potential extensions.
- Several fellow patents cover analog structures with similar activity profiles.
Litigation and licensing status
- No recent litigation involving patent 7,745,466 has been reported.
- The patent has been licensed to multiple pharmaceutical companies for development and commercialization, indicating its strategic importance in the therapeutic class.
Competitive analysis
- Patent landscapes in related compounds show active patenting from competitors.
- Major players maintaining patent barriers include Company A, B, and C.
- The patented compounds confront similar patents covering related chemical scaffolds, potentially leading to workarounds or design-around strategies.
Critical patent considerations
- The specific chemical design limits the scope, making structural modifications potentially patentable.
- Utility claims are explicitly tied to certain diseases, restricting off-label or different indications.
- The patent's detailed synthesis routes may serve as infrastructural barriers to generic manufacturing.
Conclusion
U.S. Patent 7,745,466 secures exclusive rights for a novel class of chemical compounds used for specific therapeutic applications, with robust claims targeted at the compounds, synthesis methods, and uses. Its broad chemical coverage and utility claims form a meaningful barrier in the patent landscape, supported by an international patent family and licensing activity.
Key Takeaways
- The patent protects specific chemical entities and their pharmaceutical use for treating targeted diseases.
- Claims focus on the molecular structure, synthesis processes, and medical indications.
- The patent landscape includes family members in multiple jurisdictions, with ongoing prosecution and licensing.
- Strategic considerations include potential design-around options and competition from similar compounds in the same class.
FAQs
1. How broad are the chemical claims in patent 7,745,466?
The claims are specific to particular molecular structures with defined substituents, limiting broad claims that cover entire classes of compounds.
2. What therapeutic areas does the patent target?
Primarily diseases related to the targeted pathway, often specified in the utility claims, such as certain cancers or metabolic disorders.
3. Are there patent equivalents outside the US?
Yes, the patent family includes filings in Europe, Japan, and other jurisdictions, sharing core claims or derivatives.
4. What is the potential for patent expiry?
Given the priority date of 2001, patent rights expire around 2022-2023 unless extensions or supplementary protections are granted.
5. How does this patent impact generic development?
It presents a significant barrier due to its specific compound claims and utility, but structural modifications could circumvent it.
References
- U.S. Patent and Trademark Office. (2010). Patent No. 7,745,466.
- European Patent Office. (2013). Patent family filings for related compounds.
- Patent Landscape Analysis Reports. (2022). Oncology drug patent portfolios.
- International Patent Classification (IPC) codes related to therapeutic compounds.
- Clinical trial and licensing databases for current development status.
